Milestone Approval of Invasive Brain-Computer I...

By João L. Carapinha

March 20, 2026

China's National Medical Products Administration (NMPA) has approved the world's first invasive brain-computer interface medical device for market entry. Develope...
Long-Term HPV Vaccine Effectiveness: Sustained Protection Against Cervical Di...
EU Approves Imfinzi Gastric Cancer Treatment as Perioperative Immunotherapy
Quantifying Cancer Productivity Losses in Europe: Economic Impact Analysis
Biomarin Withdraws Voxzogo Reimbursement Application in the Netherlands
Catalyzing Cardiovascular Health Innovation through Urban Interventions and C...
EMA Approval Submission for Teclistamab Multiple Myeloma Monotherapy
European Cancer Care: Balancing Economic Stability with Improved Survival Rates
FDA Warning Letter Novo Nordisk Reveals Serious Compliance Failures in Advers...
Methodological Gaps in Economic Evaluations of Vaccines: A Systematic Review
Enhertu Early Breast Cancer: FDA Priority Review for Reducing Recurrence Risk
Rapid Genetic Testing Mitigates Gentamicin-Induced Hearing Loss in Neonates
South Africa’s Push for Local Lenacapavir Production to Enhance HIV Pre...